CLIA Waiver Guidance To Address Quality Control Requirements - FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to release an interim guidance detailing the specifics of Clinical Laboratory Improvement Amendments (CLIA) waiver requirements as soon as early November, according to agency officials.